1-3 of 3
Joan Maier
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of Eltrombopag Combined with Cyclosporine As First-Line Therapy in Adults with Severe Acquired Aplastic Anemia: Results of the Interventional Phase 2 Single-Arm Soar Study

Carlos Vallejo, Jun Ho Jang, Carlo Finelli, Efreen Montaño Figueroa, Lalita Norasetthada, Rodrigo T. Calado, Mehmet Turgut, Regis Peffault De Latour, Ulrike Kriemler-Krahn, Jens Haenig, Joan Maier, Phillip Scheinberg
Journal: Blood
Blood (2021) 138 (Supplement 1): 2174.
https://doi.org/10.1182/blood-2021-147733
Published: 2021
Journal Articles

Treatment of Immune Thrombocytopenia (ITP) with Eltrombopag (EPAG) in Patients Who Did and Did Not Receive Prior Rituximab (Ritux): A Post-Hoc Analysis of the Extend Study

Oliver Meyer, James B. Bussel, MD, Raymond S Wong, MBChB, MD, Abderrahim Khelif, Miona Stankovic, Joan Maier, Mansoor N. Saleh
Journal: Blood
Blood (2018) 132 (Supplement 1): 1152.
https://doi.org/10.1182/blood-2018-99-114694
Published: 2018
Journal Articles

Eltrombopag (EPAG) Treatment Improved Platelet Counts in Patients with Persistent or Chronic Immune Thrombocytopenia during a 2-Year, Phase IV, Open-Label Study

Raymond SM Wong, MRCP,FRCP, Russell K Brynes, Attilio Orazi, Zeba Aziz, MD MBBS, Anait L. Melikyan, MD PhD, Abdulgabar Salama, Ozlem Ocak Arikan, Joan Maier, Tahir Shamsi, Professor of Haematology (FRCPath)
Journal: Blood
Blood (2017) 130 (Supplement 1): 3628.
https://doi.org/10.1182/blood.V130.Suppl_1.3628.3628
Published: 2017